|
|
G.A. FitzGerald
J Clin Invest. 2002;
110(1):33
doi:10.1172/JCI16044
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(4)
| Title and authors |
Publication |
Year |
Prostaglandin F2 elevates blood pressure and promotes atherosclerosis
Y. Yu, M. B. Lucitt, J. Stubbe, Y. Cheng, U. G. Friis, P. B. Hansen, B. L. Jensen, E. M. Smyth, G. A. FitzGerald
|
Proceedings of the National Academy of Sciences
|
2009 |
Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function.
Dairong Wang, Vickas V Patel, Emanuela Ricciotti, Rong Zhou, Mark D Levin, Ehre Gao, Zhou Yu, Victor A Ferrari, Min Min Lu, Junwang Xu, Hualei Zhang, Yiqun Hui, Yan Cheng, Nataliya Petrenko, Ying Yu, Garret A FitzGerald
|
Proc. Natl. Acad. Sci. U.S.A.
|
2009 |
Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs
Marc Maillard, Michel Burnier
|
Expert Opin. Drug Saf.
|
2006 |
COX-2 and beyond: approaches to prostaglandin inhibition in human disease
Garret A. FitzGerald
|
Nat Rev Drug Discov
|
2003 |
|
